Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05031468 · ClinicalTrials.gov registry record
Multisite Observational Maternal and Infant Study for COVID-19
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 562
- Enrollment target
NCT05031468: Completed study, sponsored by Emory University.
NCT05031468 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 562 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05031468 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 562 participants
- Enrollment target
Study Summary
This is an observational, non-interventional, prospective cohort study designed to collect clinical information and specimens to evaluate the immune responses from pregnant individuals and postpartum individuals and their infants following maternal receipt of licensed or Emergency Use Authorization (EUA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines.
Primary Outcome
The kinetics and durability of maternal serum antibodies following receipt of SARS-CoV-2 vaccine during pregnancy will be assessed as the GMT of IgG enzyme-linked immunosorbent assay (ELISA), by vaccine type and/or platform (mRNA, viral vector, etc.).
Interventions
- BIOLOGICAL Licensed or EUA SARS-CoV-2 vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 562 participants |
| Start Date | 2021-07-06 |
| Est. Completion | 2023-08-16 |
What the finished NCT05031468 record still lists
NCT05031468 is an observational study that tracks outcomes without assigning an intervention. The registered 562 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Licensed or EUA SARS-CoV-2 vaccine is the first listed.
NCT05031468 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05031468 about?
NCT05031468 is a clinical study titled "Multisite Observational Maternal and Infant Study for COVID-19". This is an observational, non-interventional, prospective cohort study designed to collect clinical information and specimens to evaluate the immune responses from pregnant individuals and postpartum individuals and their infants following maternal receipt of licensed or Emergency Use Authorization ...
What is the current status of trial NCT05031468?
This trial is currently completed. The enrollment target is 562 participants. The study started on 2021-07-06. Estimated completion is 2023-08-16.
What interventions are being tested in trial NCT05031468?
The interventions under investigation include: Licensed or EUA SARS-CoV-2 vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05031468?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07007065 · 561 participants · Phase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- NCT06146725 · 564 participants
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- NCT06188520 · 564 participants · Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- NCT06628453 · 564 participants · NA
CGM for Management of Type 2 Diabetes in Pregnancy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI